It depends on whether the model actually needs that extra discharge capability
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial
Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase
The drug's off-label use for weight loss was noticed by providers and patients almost immediately, and Novo Nordisk responded by developing Wegovy, which also featured the same semaglutide molecule, just at a higher dose
Taking too much can make side effects, like feeling or being sick, diarrhoea, or headaches, worse and increase the chance of dehydration
is cofounder of and holds shares in Keapstone Therapeutics, collaborates and receives funding from BenevolentAI, Quell Therapeutics, Sosei Heptares and MSD, is a consultant to Aclipse Therapeutics, has shares in Aclipse One Inc and is an inventor on patents related to M102